Erenumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Antimigraine drug Calcitonin gene-related peptide receptor antagonist Monoclonal antibody Novartis brand Signaling peptide/protein receptor modulator Therapeutic monoclonal antibody
rdfs:label	Erenumab
owl:sameAs	dbr:Erenumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Signaling_peptide_receptor http://en.wikipedia.org/wiki/Category:Antimigraine_drugs http://en.wikipedia.org/wiki/Category:Calcitonin_gene-related_peptide_receptor_antagonists http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Novartis_brands http://en.wikipedia.org/wiki/List_of_signaling_peptide/protein_receptor_modulators http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy
skos:prefLabel	Erenumab
skos:altLabel	erenumab
clgo:alternativeName	Aimovig
clgo:bioavailability	82.0
clgo:casNumber	1582205-90-0
clgo:chEMBL	3833329
clgo:drugbank	DB14039
clgo:fdaUniiCode	I5I8VB78VT
clgo:kegg	D10928
clgo:medlinePlus	a618029
is clgo:product of	Amgen

About: clgr:Erenumab